🇺🇸 FDA
Patent

US 9827290

Compositions and methods relating to induction of intestinal stem cell homeogenesis and/or regeneration

granted A61KA61K38/1709A61K38/179

Quick answer

US patent 9827290 (Compositions and methods relating to induction of intestinal stem cell homeogenesis and/or regeneration) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/1709, A61K38/179, A61K38/18, A61K45/06